Bristol-Myers Squibb Co BMY reported upbeat second-quarter earnings and lifted its 2011 projections.
Bristol-Myers reported its quarterly earnings at $902 million, or $0.52 per share, down from $927 million, or $0.53 per share, in the year-earlier period. Its revenue surged 14% y/y to $5.4 billion. Bristol-Myers' adjusted earnings came in at $971 million, or $0.56 per share. However, analysts were expecting earnings of $0.55 per share on revenue of $5.05 billion.
Bristol-Myers Squibb lifted its 2011 adjusted earnings forecast to a range of $2.20 to $2.30 per share.
BMY shares closed at $28.61 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in